| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062047 | Annals of Allergy, Asthma & Immunology | 2013 | 7 Pages |
Abstract
In a systematic review using the GRADE system, the strength of recommendation is weak for use of SIT in patients with AD. High-quality evidence from methodologically sound double-blinded randomized controlled trials is needed to support administration of SIT for patients with AD.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Samantha R. MD, David M. MD,